Computational model of obsessive-compulsive disorder: examination of etiologic hypothesis and treatment strategies.
Research has shown that obsessive compulsive disorder (OCD) is related to structural and functional abnormalities in the brain, and several authors have organized these findings into theories of OCD neuropsychiatric dysfunction. In this paper, these theories were used to develop a neural network model of OCD. OCD symptoms were hypothesized to result from a hyperactive orbitofrontal-striato-thalamic-orbitofrontal neural loop. The network was constructed and trained with a backpropagation algorithm, and it was then used to assess etiologic theories of OCD (e.g., basal ganglia dysfunction, inadequate dopaminergic inhibitory influence on basal ganglia and excessive input from the limbic system). The network was also observed in analogues of the treatment of OCD with serotonergic medications and behavior therapy. Results show that a) the network behaved both normally and abnormally, depending on what combinations of perceptual, motivational, and neurochemical inputs were presented to it; b) several etiologic mechanisms produced changes in the networks' behaviors similar to patients' subjective experiences of OCD symptoms; and c) different treatment strategies, both those modeled as pharmacologic and behavioral therapies, produced reductions in simulated OCD symptoms.
Ownby
R L
RL
Department of Psychiatry, University of Miami School of Medicine, Miami Beach, FL 33140, USA.
D000465:Algorithms; D000704:Analysis of Variance; D001479:Basal Ganglia / Q000187:drug effects / Q000503:physiopathology; D001521:Behavior Therapy; D001927:Brain Diseases / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D002540:Cerebral Cortex / Q000503:physiopathology; D016009:Chi-Square Distribution; D003198:Computer Simulation; D004359:Drug Therapy, Combination; D006801:Humans; D008032:Limbic System / Q000187:drug effects / Q000503:physiopathology; D008959:Models, Neurological; D009415:Nerve Net; D009433:Neural Inhibition / Q000187:drug effects; D016571:Neural Networks, Computer; D009771:Obsessive-Compulsive Disorder / Q000209:etiology* / Q000628:therapy*; D011903:Raphe Nuclei / Q000503:physiopathology; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D013788:Thalamus / Q000503:physiopathology
D017367:Selective Serotonin Reuptake Inhibitors